Home  - Health_Conditions - Myelodysplastic Syndromes

Books Baby Camera Phones Computers Games DVD Electronics Kitchen Magazines Music Garden Software Tools Toys Video Apparel & Accessories Jewelry & Watches Musical Instruments Health & Personal Care Beauty Sports & Outdoors Office Products

e99.com Bookstore

Images

Newsgroups

41-60 of 102    Back | 1  | 2  | 3  | 4  | 5  | 6  | Next 20

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Myelodysplastic Syndromes:     more books (49)

Gale Encyclopedia of Medicine: Myelodysplastic syndrome by Andrea Ruskin M.D., 2002-01-01 Update on Myelodysplastic Syndrome: An Essay Submitted for Partial Fulfillment of The Master Degree in Clinical and Chemical Pathology 2008 by Ahmed Abdellatif, 2010-10-21 J&b Clinical Care: Myelodysplastic Syndromes Clinical Card - 10 Pack by John M. Bruke, 2009-01 Molecular characterization of 5q deletions in myelodysplastic syndromes by Marian Stevens-Kroef, 1998 Hematology/oncology Clinics of North America (Myelodysplastic Syndromes, 6, Number 3) Myelodysplastic Syndromes: From Biology To The Clinic by Peter L. Greenberg, 2005 Myelodysplastic Syndromes and Secondary Acute Myelogenous Leukemia by Azra Raza, 2003 Myelodysplastic syndrome 'severely underestimated'.(NEWS)(Report): An article from: Internal Medicine News by Robert Finn, 2009-02-01 The myelodysplastic syndromes: Proceedings of the Pekka Vuopio Memorial Symposium held in Espoo, Finland ... 1985 100 Q & A about Myelodysplastic Syndromes by Jason Gotlib, 2007-01-01 100 Questions & Answers About Myelodysplastic Syndromes Hematopoietic Stem Cell Transplantation (Contemporary Hematology) Sanctura, Vidaza.(New & Approved): An article from: Skin & Allergy News by Elizabeth Mechcatie, 2004-08-01 Sideroblastic Anemia: An entry from Gale's <i>Gale Encyclopedia of Medicine, 3rd ed.</i> by Maureen Haggerty, 2006

lists with details

41. NEJM -- Efficacy Of Lenalidomide In Myelodysplastic Syndromes
    Original Article from The New England Journal of Medicine Efficacy of Lenalidomidein myelodysplastic syndromes.  
    http://content.nejm.org/cgi/content/short/352/6/549
    
    Extractions: Full Text PDF PDA Full Text PowerPoint Slide Set ... PubMed Citation ABSTRACT Background Ineffective erythropoiesis is the hallmark of myelodysplastic syndromes. Management of the anemia caused by ineffective erythropoiesis is difficult. In patients with myelodysplastic syndromes and symptomatic anemia, we evaluated the safety and hematologic activity of lenalidomide, a novel analogue of thalidomide. Methods Forty-three patients with transfusion-dependent or symptomatic anemia received lenalidomide at doses of 25 or 10 mg per day or of 10 mg per day for 21 days of every 28-day cycle. All patients either had had no response to recombinant erythropoietin or had a high endogenous erythropoietin level with a low probability of benefit from such therapy. The response to treatment was

42. NEJM -- Myelodysplastic Syndromes -- Coping With Ineffective Hematopoiesis
    Perspective from The New England Journal of Medicine myelodysplastic syndromes Coping with Ineffective Hematopoiesis.  
    http://content.nejm.org/cgi/content/short/352/6/536
    
    Extractions: Letters ... PubMed Citation One of the most challenging problems in hematology is the heterogeneous group of disorders that were formally defined as myelodysplastic Group in 1982. This set of disorders includes idiopathic conditions as well as the secondary or therapy-related forms that develop after exposure to alkylating agents, radiation, or both. Idiopathic myelodysplastic syndromes occur mainly in older persons: the incidence of these syndromes is about 5 per 100,000 persons per year in the general population, but it increases to 20 to 50 per 100,000 persons per year after 60 years of age. Approximately 15,000 new cases are Full Text of this Article

43. Myelodysplastic Syndromes (MDS)
    238.7 Myelodysplastic syndrome REFERENCES; Hoffman R, Benz EJ Jr, Shattil S, etal, eds Hematology Basic Principles and Practice. 3rd Ed. New York,  
    http://www.5mcc.com/Assets/SUMMARY/TP0609.html

44. Myelodysplastic Syndromes - CancerIndex
    These myelodysplastic syndromes can occur in all age groups but are more common myelodysplastic syndromes may develop spontaneously or be secondary to  
    http://www.cancerindex.org/clinks4d.htm
    
    Extractions: Myelodysplastic Syndromes Home Cancer Types Hematological Myelodysplastic Syndromes Myelodysplastic syndromes, sometimes called "pre-leukaemia" are a group of diseases in which the bone marrow does not produce enough normal blood cells. Common symptoms are anaemia, bleeding, easy bruisability, and fatigue. These Myelodysplastic syndromes can occur in all age groups but are more common in people aged over 60. Myelodysplastic syndromes may develop spontaneously or be secondary to treatment with chemotherapy / radiotherapy. There is an association with Myelodysplastic syndromes and acute myeloid leukaemia. Patient's information for Myelodysplastic Syndromes (CancerNet) Information about the disease, staging, and treatment overviews. It is reviewed each month by a panel of medical experts. Myelodysplastic Syndrome - Booklet (Leukemia and Lymphoma Society, USA) Myelodysplastic Syndromes (Leukemia Research Fund , UK) on-line booklet Myelodysplastic Syndromes Foundation The Foundation was established by a group of international physicians and researchers to provide an ongoing exchange of information about MDS. The web site includes information for patients, health professionals and researchers.

45. Introduction: Myelodysplastic Syndromes - WrongDiagnosis.com
    Introduction to myelodysplastic syndromes as a medical condition includingsymptoms, diagnosis, misdiagnosis, treatment, prevention, and prognosis.  
    http://www.wrongdiagnosis.com/m/myelodysplastic_syndromes/intro.htm
    
    Extractions: Causes of Myelodysplastic syndromes: Research more detailed information about the causes of Myelodysplastic syndromes , other possibly hidden causes of Myelodysplastic syndromes , or other general information about Myelodysplastic syndromes Statistics and Myelodysplastic syndromes: Various sources and calculations are available in statistics about Myelodysplastic syndromes prevalence and incidence statistics for Myelodysplastic syndromes , and you can also research other medical statistics in our statistics center

46. Protocols For Myelodysplastic Syndromes - UMass Medical School
    for the Treatment of myelodysplastic syndromes and Acute Myeloid Leukemia . of patients with intermediate and high risk myelodysplastic syndromes.  
    http://www.umassmed.edu/hema_oncology/mdscenter/mdsprotocols.cfm

47. ACOR Leukemia Links: Resources For Myelodysplasia & Myeloproliferative Disorders
    Resources for Myelodysplasia or myelodysplastic syndromes The NCI PDQ patientstatement on myelodysplastic syndromes (or myelodysplasia).  
    http://leukemia.acor.org/mpd.html

48. University Of Florida Shands Cancer Center: Myelodysplastic Syndrome
    myelodysplastic syndromes are a group of diseases characterized by the body’s The myelodysplastic syndromes are really several different diseases,  
    http://www.ufscc.ufl.edu/content.aspx?section=typesofcancer&id=842

49. University Of Florida Shands Cancer Center: Latest Cancer News
    Revlimid® Shows Promise for myelodysplastic syndromes (5/23/2005) Dacogenâ?¢Effective in myelodysplastic syndromes (4/27/2005)  
    http://www.ufscc.ufl.edu/cancernews.aspx?section=cancernews&display=summary&cid=

50. Myelodysplastic Syndromes/Myeloproliferative Disorders
    Online health news and information for consumers.  
    http://www.stayinginshape.com/3osfcorp/libv/i80.shtml
    
    Extractions: HEART CANCER WOMEN MEN ... ALL TOPICS A - Z Myelodysplastic syndromes (MDS) and myeloproliferative disorders are diseases of the blood and bone marrow. The National Cancer Institute (NCI) says myelodysplastic syndromes are the result of not enough healthy blood cells being produced. Myeloproliferative disorders are the result of too many blood cells being produced. The American Cancer Society (ACS) estimates that each year 10 to 15 thousand people are diagnosed with MDS. Most of them are over 60 years of age and more men than women are affected. MDS has not always been considered a cancer, according to ACS but is now being considered a form of cancer. ACS also says about 30 percent of MDS cases progress to become acute myeloid leukemia. (Read about " Leukemia ") NCI says basically the bone marrow does not make enough healthy blood cells. The key word there is healthy. Many of the cells that are created are abnormal. Normally, the bone marrow produces stem cells (immature cells) that develop into mature blood cells. There are 3 types of mature blood cells: Red blood cells that carry oxygen and other materials to all tissues of the body White blood cells that fight infection and disease (Read about "

51. Myelodysplastic Syndrome, Information, Seattle, Washington, What Is Myelodysplas
    Patients with myelodysplastic syndrome may also bleed without obvious reason, myelodysplastic syndromes Foundation www.mdsfoundation.org  
    http://www.seattlecca.org/patientsandfamilies/adultCare/clinicalProgs/Myelodyspl
    
    Extractions: Home Adult Care Clinical Services Myelodysplastic Syndrome (MDS) > Patient Education Choose a Diagnosis Autoimmune Diseases Bladder Cancer Blood Disorders Bone Marrow Transplant Breast Cancer Breast Cancer in Men Breast Health Cervical Cancer Colorectal Cancer Endometrial Cancer Gastrointestinal Cancer Prevention Gestational Trophoblastic Disease Gynecologic Cancers Kidney Cancer Leukemia Liver Cancer Lung Cancer Lymphoma Melanoma Mesothelioma Multiple Myeloma Myelodysplastic Synd. Ovarian Cancer Pancreatic Cancer Pediatric Cancer Pediatric Bone Marrow Transplant Prostate Cancer Sarcoma Skin Cancer Stomach Cancer Vulvar Cancer What is Myelodysplastic Syndrome?

52. Mds04
    CME Information MDS Presentations CME Information myelodysplastic syndromesDiagnosis and Emerging Therapies  
    http://www.bloodline.net/mds04/

53. Myelodysplastic Syndromes - Patient UK
    myelodysplastic syndromes Patient UK. A directory of UK health, disease, illnessand related medical websites that provide patient information.  
    http://www.patient.co.uk/showdoc/40024635/
    
    Extractions: PatientPlus articles are written for doctors and so the language can be technical. However, some people find that they add depth to the articles found in the other sections of this website which are written for non-medical people. Group of acquired clonal disorders affecting the haemopoietic system involving a defect in an early progenitor cell and therefore MDS can affect many cells. Previously have been referred to as pre-leukaemias, smouldering leukaemias and refractory anaemias. In many forms of MDS there are chromosomal abnormalities particularly including deletions of chromosomes 5 and 7 and trisomy 8. Primary acquired sideroblastic anaemia caused by disruption in haem synthesis (associated with consumption of alcohol, isoniazid or pyrazinamide) in a particular form of MDS. Epidemiology Risk Factors Presentation Investigations Blood film and FBC (useful to see results over time), all cases show anaemia either normocytic or macrocytic. Blood film characteristically shows dysplasia as erythrocytes with anisocytosis (varying sizes), poikilocytosis (abnormal shape) and basophilic stippling. Polymorphs are commonly hypolobulated and may show characteristic bilobed appearance. May also be hypogranulation and abnormal chromatin.

54. Stanford Cancer Center - Myelodysplastic Syndromes (MDS) | Cancer Types | Stanfo
    myelodysplastic syndromes (MDS) are a group of diseases that cause immature bloodcells (called blasts) to accumulate in the bone marrow leading to a  
    http://cancer.stanfordhospital.com/cancerTypes/leukemias/MDS/default
    
    Extractions: Home For Patients For Health Professionals Students ... Leukemias Myelodysplastic Syndromes (MDS) Myelodysplastic syndromes (MDS) are a group of diseases that cause immature blood cells (called blasts) to accumulate in the bone marrow leading to a shortage of mature blood cells, including red blood cells, white blood cells, and platelets. Furthermore, the mature blood cells that are made can also be defective. MDS are not cancer themselves, but about 30% of the time the syndromes are a precursor to leukemias such as  acute myeloid leukemia (AML)  and  chrome myelomonocytic leukemia (CMML) Although MDS can affect people of all ages, the median age of onset is 65. MDS affects less than 15,000 people each year in the United States, and includes the following syndromes: People who have received radiation therapy, chemotherapy with alkylating agents (such as chlorambucil, cyclophosphamide, and melphalan), or who have been exposed to industrial solvents (such as benzene) have a higher risk of developing MDS than people who have not had these exposures. Rarely, genetic disorders are responsible for the disease. Nevertheless, in 60% to 70% of MDS patients, no specific cause can be identified. The Stanford MDS Center has been recognized by the MDS Foundation as an MDS Center of Excellence. In addition, physicians in the Center participate in developing national treatment guidelines, serve on the boards of MDS organizations, and are actively involved in clinical trials for MDS.

55. Myelodysplastic Syndromes
    A booklet, aimed at patients, about myelodysplastic syndromes. A collectionof resources on myelodysplastic syndromes including statistics,  
    http://omni.ac.uk/browse/mesh/D009190.html
    
    Extractions: low graphics broader: Bone Marrow Diseases other: Anemia, Aplastic Myeloproliferative Disorders narrower: Hemoglobinuria, Paroxysmal Leukemia, Myeloid Myelodysplastic syndromes A booklet, aimed at patients, about myelodysplastic syndromes. The booklet explains the types, causes, signs and symptoms, diagnosis, treatment, and prognosis of myelodysplastic syndromes (a group of diseases in which the production of blood cells is disrupted). Published on the Web by the Leukaemia Research Fund. Patient Education Handout [Publication Type] Myelodysplastic Syndromes Chronic myeloid leukaemia information centre Patient Education Handout [Publication Type] ... Myelodysplastic syndromes A collection of resources on myelodysplastic syndromes including statistics, and access to relevant guidelines, further reading, Medline searches, papers, trials, patient information, and other resources (including Web sites). The resources will be of interest to a professional and lay audience. Published on the Web by the Leukaemia Research Fund. Myelodysplastic Syndromes Myelodysplastic Syndromes Foundation The Myelodysplastic Syndromes Foundation (MSF) is a US based organisation established by an international group of physicians and researchers to provide an ongoing exchange of information relating to myelodysplastic syndromes (MDS). The site provides informatiion about the organisation, the causes of MDS, publications, an International Patient Registry, and links to sites of related interest. There is access to newsletters, The MDS News, full-text articles and selected abstracts from relevant journals. It has International Research Updates which contain details of current trials in the USA and Europe. A range of patient information resources are available in PDF, which requires Adobe Acrobat Reader. The site is aimed at patients, families, and physicians.

56. UpToDate Patient Information: Myelodysplastic Syndromes (MDS)
    The myelodysplastic syndromes (MDS, myelodysplasia) are not one specific disease, Clinical manifestations and diagnosis of the myelodysplastic syndromes  
    http://patients.uptodate.com/topic.asp?file=blod_dis/6748

57. UpToDate Clinical Manifestations And Diagnosis Of The Myelodysplastic Syndromes
    INTRODUCTION — The myelodysplastic syndromes (MDS) comprise a heterogeneous groupof malignant stem cell disorders characterized by dysplastic and  
    http://patients.uptodate.com/topic.asp?file=leukemia/14065

58. Rural Nurse Organization Clinic Digital Library
    Myelodysplastic Syndrome (MDS) Peripheral Blood Access document; MDS Bone MarrowAccess myelodysplastic syndromes Treatment Table of contents  
    http://ruralnurseorganization-dl.slis.ua.edu/clinical/hematology/anemias/myelody
    
    Extractions: Clinical Resources by Topic: Hematology Myelodysplastic Syndrome Clinical Resources Pediatrics Geriatrics Pathology Clinical Guidelines ... Miscellaneous Resources See also: Chapter 127: Anemias: Table of contents Medicine, Ob/Gyn, Psychiatry, and Surgery (eMedicine): Table of contents Pediatrics Resources See also General Pediatrics Resources Geriatrics Resources See also General Geriatrics Resources Merck Manual of Geriatrics: Table of contents Chapter 73. Hematologic Malignancies:

59. MedlinePlus: Bone Marrow Diseases
    Overviews; What Are myelodysplastic syndromes and Statistics; What Are theKey Statistics about Myelodysplastic Syndrome? (American Cancer Society)  
    http://www.nlm.nih.gov/medlineplus/bonemarrowdiseases.html
    
    Extractions: Also available in: Spanish Myelodysplastic/Myeloproliferative Diseases (PDQ): Treatment (National Cancer Institute) Overviews What Are Myelodysplastic Syndromes and Myelodysplastic/Myeloproliferative Diseases? (American Cancer Society) Diagnosis/Symptoms Platelet Count (American Association for Clinical Chemistry) Understanding Your Complete Blood Count (National Institutes of Health, Clinical Center) - Links to PDF

60. Medifocus: Myelodysplastic Syndrome Guidebook
    myelodysplastic syndromes (MDS) are a group of myeloid stem cell disorders The MediFocus Guidebook on Myelodysplastic Syndrome contains information that  
    http://www.medifocus.com/myelodysplastic-syndrome.php?a=a

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

41-60 of 102    Back | 1  | 2  | 3  | 4  | 5  | 6  | Next 20